Earnings Feed
Start Free
NABI BIOPHARMACEUTICALS·4

Apr 5, 5:25 PM ET

FAHIM RAAFAT E F 4

4 · NABI BIOPHARMACEUTICALS · Filed Apr 5, 2011

Insider Transaction Report

Form 4
Period: 2011-04-01
NABI BIOPHARMACEUTICALSNABI
FAHIM RAAFAT E F
DirectorPresident, CEO and CFO
Transactions
  • Other

    Common Stock

    [F1]
    2010-05-31$4.20/sh+3,096$13,003→ 333,733.941 total
  • Other

    Common Stock

    [F1]
    2010-11-30$4.30/sh+3,023$12,999→ 336,756.941 total
  • Award

    Common Stock

    [F2]
    2011-04-01+50,000→ 386,756.941 total
  • Sale

    Common Stock

    [F3]
    2011-04-05$5.76/sh−13,283$76,458→ 373,473.941 total
  • Award

    Stock Option (right to buy)

    [F4]
    2011-04-01+150,000→ 150,000 total
    Exercise: $5.81Exp: 2018-04-01→ Common Stock (150,000 underlying)
Footnotes (4)
  • [F1]Voluntarily reported acquisition under the Issuer's 2000 Employee Stock Purchase Plan, which is an exempt transaction pursuant to Rule 16b-3.
  • [F2]Restricted Stock which vests in four equal annual installments beginning on April 1, 2012.
  • [F3]This disposition was made to fund the Reporting Person's tax obligation arising from the vesting of restricted stock.
  • [F4]This Option will become exercisable in four equal annual installments beginning on April 1, 2012.
Signature
James E. Dawson, as attorney-in-fact|2011-04-05

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT